BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

641 related articles for article (PubMed ID: 33618627)

  • 21. Decoding cell death signals in liver inflammation.
    Brenner C; Galluzzi L; Kepp O; Kroemer G
    J Hepatol; 2013 Sep; 59(3):583-94. PubMed ID: 23567086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interplay between bile acids and the gut microbiota promotes intestinal carcinogenesis.
    Wang S; Dong W; Liu L; Xu M; Wang Y; Liu T; Zhang Y; Wang B; Cao H
    Mol Carcinog; 2019 Jul; 58(7):1155-1167. PubMed ID: 30828892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bile acids are nutrient signaling hormones.
    Zhou H; Hylemon PB
    Steroids; 2014 Aug; 86():62-8. PubMed ID: 24819989
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diet as a modifiable factor in tumorigenesis: Focus on microbiome-derived bile acid metabolites and short-chain fatty acids.
    Ahmad F; Saha P; Singh V; Wahid M; Mandal RK; Nath Mishra B; Fagoonee S; Haque S
    Food Chem; 2023 Jun; 410():135320. PubMed ID: 36610090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Altered gut microbiome, bile acid composition and metabolome in sarcopenia in liver cirrhosis.
    Aliwa B; Horvath A; Traub J; Feldbacher N; Habisch H; Fauler G; Madl T; Stadlbauer V
    J Cachexia Sarcopenia Muscle; 2023 Dec; 14(6):2676-2691. PubMed ID: 37767786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reprint of Neutrophil cell surface receptors and their intracellular signal transduction pathways.
    Futosi K; Fodor S; Mócsai A
    Int Immunopharmacol; 2013 Dec; 17(4):1185-97. PubMed ID: 24263067
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lithocholic Acid Induces miR21, Promoting PTEN Inhibition via STAT3 and ERK-1/2 Signaling in Colorectal Cancer Cells.
    Nguyen TT; Ung TT; Li S; Sah DK; Park SY; Lian S; Jung YD
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638550
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences in Fecal Gut Microbiota, Short-Chain Fatty Acids and Bile Acids Link Colorectal Cancer Risk to Dietary Changes Associated with Urbanization Among Zimbabweans.
    Katsidzira L; Ocvirk S; Wilson A; Li J; Mahachi CB; Soni D; DeLany J; Nicholson JK; Zoetendal EG; O'Keefe SJD
    Nutr Cancer; 2019; 71(8):1313-1324. PubMed ID: 31007075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metagenomic and targeted metabolomic analyses reveal distinct phenotypes of the gut microbiota in patients with colorectal cancer and type 2 diabetes mellitus.
    Yang Y; Han Z; Gao Z; Chen J; Song C; Xu J; Wang H; Huang A; Shi J; Gu J
    Chin Med J (Engl); 2023 Dec; 136(23):2847-2856. PubMed ID: 36959686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical efficacies, underlying mechanisms and molecular targets of Chinese medicines for diabetic nephropathy treatment and management.
    Tang G; Li S; Zhang C; Chen H; Wang N; Feng Y
    Acta Pharm Sin B; 2021 Sep; 11(9):2749-2767. PubMed ID: 34589395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy.
    Palomer X; Salvadó L; Barroso E; Vázquez-Carrera M
    Int J Cardiol; 2013 Oct; 168(4):3160-72. PubMed ID: 23932046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kaempferol acts on bile acid signaling and gut microbiota to attenuate the tumor burden in ApcMin/+ mice.
    Li X; Khan I; Huang G; Lu Y; Wang L; Liu Y; Lu L; Hsiao WLW; Liu Z
    Eur J Pharmacol; 2022 Mar; 918():174773. PubMed ID: 35065044
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New possible silver lining for pancreatic cancer therapy: Hydrogen sulfide and its donors.
    Hu X; Xiao Y; Sun J; Ji B; Luo S; Wu B; Zheng C; Wang P; Xu F; Cheng K; Hua H; Li D
    Acta Pharm Sin B; 2021 May; 11(5):1148-1157. PubMed ID: 34094825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of SCFAs in gut microbiome and glycolysis for colorectal cancer therapy.
    Wang G; Yu Y; Wang YZ; Wang JJ; Guan R; Sun Y; Shi F; Gao J; Fu XL
    J Cell Physiol; 2019 Aug; 234(10):17023-17049. PubMed ID: 30888065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gut-liver axis-mediated mechanism of liver cancer: A special focus on the role of gut microbiota.
    Ohtani N; Hara E
    Cancer Sci; 2021 Nov; 112(11):4433-4443. PubMed ID: 34533882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Downregulation of the farnesoid X receptor promotes colorectal tumorigenesis by facilitating enterotoxigenic Bacteroides fragilis colonization.
    Guo S; Peng Y; Lou Y; Cao L; Liu J; Lin N; Cai S; Kang Y; Zeng S; Yu L
    Pharmacol Res; 2022 Mar; 177():106101. PubMed ID: 35104632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anoikis molecular pathways and its role in cancer progression.
    Paoli P; Giannoni E; Chiarugi P
    Biochim Biophys Acta; 2013 Dec; 1833(12):3481-3498. PubMed ID: 23830918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug Discovery and Repurposing Inhibits a Major Gut Pathogen-Derived Oncogenic Toxin.
    Metz P; Tjan MJH; Wu S; Pervaiz M; Hermans S; Shettigar A; Sears CL; Ritschel T; Dutilh BE; Boleij A
    Front Cell Infect Microbiol; 2019; 9():364. PubMed ID: 31709196
    [No Abstract]   [Full Text] [Related]  

  • 39. Dietary fat and gut microbiota interactions determine diet-induced obesity in mice.
    Kübeck R; Bonet-Ripoll C; Hoffmann C; Walker A; Müller VM; Schüppel VL; Lagkouvardos I; Scholz B; Engel KH; Daniel H; Schmitt-Kopplin P; Haller D; Clavel T; Klingenspor M
    Mol Metab; 2016 Dec; 5(12):1162-1174. PubMed ID: 27900259
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protective effect of the "food-microorganism-SCFAs" axis on colorectal cancer: from basic research to practical application.
    Shuwen H; Miao D; Quan Q; Wei W; Zhongshan Z; Chun Z; Xi Y
    J Cancer Res Clin Oncol; 2019 Sep; 145(9):2169-2197. PubMed ID: 31401674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.